Non-alcoholic fatty liver disease (NAFLD) is a serious health problem due to its high
incidence and consequences. In view of the existing controversies, new therapeutic options …

Nonalcoholic fatty liver disease (NAFLD, including nonalcoholic fatty liver (NAFL) and
nonalcoholic steatohepatitis (NASH)) is a high-prevalence disorder, affecting about 1 billion …

The essential oil of the resinous exudate from Pistacia lentiscus of Chios namely Chios
Mastiha Essential Oil (CMEO), is a natural volatile oil rich in monoterpenes α-pinene, β …

Mastiha is a natural nutritional supplement with known anti-inflammatory properties. Non-
alcoholic fatty liver disease (NAFLD) and Inflammatory bowel disease (IBD) are immune …

Advances in sequencing technologies over the past 15 years have led to a substantially
greater appreciation of the importance of the gut microbiome to the health of the host …

Non-alcoholic fatty liver disease (NAFLD) has recently become the most common liver
disease with a global prevalence of over 25% and is expected to increase. Recently, experts …

Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease with no
therapeutic consensus. Oxidation and inflammation are hallmarks in the progression of this …

Background As the number of patients with skin allergies, including atopic dermatitis, has
increased rapidly, therapeutic options such as anti-IL-31 antibody and Janus kinase inhibitor …

Non-alcoholic fatty liver disease (NAFLD) is the most common chronic liver disease around
the world, and it often coexists with insulin resistance-related diseases including obesity …

Over the past two decades, non-alcoholic fatty liver disease (NAFLD) has become a leading
burden of hepatocellular carcinoma and liver transplantation. Although the exact …